STUDY

IPL and the Vbeam laser reduced rosacea redness about the same

“Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea.” Neuhaus IM et al. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. June 2009

Neuhaus IM et al. · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · June 2009

Randomized split-face trial
The finding

After three sessions, both IPL and Vbeam improved facial redness and visible vessels, with no clear difference in this small trial.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Randomized, single-blind, split-face trial. The trial compared Vbeam, IPL, and an untreated control in assigned half-face combinations.
At a glance

Who was studied and for how long

Completed
29 people
Moderate facial redness and visible vessels
Sessions
Three
One month apart
Compared
IPL and Vbeam
Included untreated control areas
Follow-up
1 month
After the last treatment
What they did

How the study worked

29 completedfacial rosaceaRANDOMSPLITVbeamAssigned side · 595 nm pulsed dyeIPLAssigned side · 560 nm filterUntreated controlAssigned side · no treatmentMEASURED ATOne month laterafter final session29 completedfacial rosaceaRANDOMSPLITVbeamAssigned side · 595 nm pulsed dyeIPLAssigned side · 560 nm filterUntreated controlAssigned side · no treatmentMEASURED ATOne month laterafter final session
Assign face sidesParticipants were assigned combinations of IPL, pulsed dye laser or an untreated control.
Treat monthlyThe study used an IPL Quantum and a 595 nm Vbeam with settings aimed at avoiding lasting bruising.
Measure rednessA device measured redness and a masked clinician graded redness and visible vessels.
What they found

The results

VbeamIPLUntreated control

Redness and visible blood vessels

At one month after the last session, masked ratings showed improvement with both devices compared with untreated skin. The trial found no clear difference between the two devices on those ratings.

Would choose the treatment again

Patient preference was a separate outcome. The study used different treatment pairings, so the denominators differ.

Vbeam
96%
IPL
80%
The study tracked redness, visible vessels and symptoms. The preference question asked whether patients would repeat treatment. Twenty-five of 26 said yes for Vbeam, and 20 of 25 said yes for IPL.
How much to trust it

Strengths and limits

Strengths

  • Included untreated control areas
  • Masked clinician assessment
  • Specified the two devices and treatment settings

Limits

  • Only 29 people completed the study
  • Outcomes assessed one month after the final session
  • Other device settings or rosacea symptoms may respond differently
Moderate confidence. The trial included untreated areas and masked ratings. Only 29 people completed it, and the follow-up was short.
What it means for you

The takeaway

Both reduced redness

The tested IPL and Vbeam settings both improved redness and visible vessels over three sessions.

Pages that cite this study

Read more on Dermapedia

Terms in this study

Words worth knowing

IPL

Intense pulsed light, which delivers a range of wavelengths.

Vbeam

A brand of pulsed dye laser.

Telangiectasia

Small blood vessels visible at the skin surface.

Original source

Neuhaus IM, Zane LT, Tope WD. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea.. Dermatol Surg. 2009;35(6):920–928.

PMID 19397667